Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Aug 28, 2026

DMII — Drugs Made In America Acquisition II Corp. Dilution Risk Tracker

Track DMII dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DMII — Get alerts when the score changes →

As of August 28, 2026, Drugs Made In America Acquisition II Corp. (DMII) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Drugs Made In America Acquisition II Corp. has a market capitalization of $640.82M, 63.70M shares outstanding, 68 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 30%
💰 Capital Raise model 55%
• Critical: only 2.1 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track DMII — Get forecast alerts →

Market Data

Market Cap$640.82M
Shares Outstanding63.70M
Float50.26M
Cash$175.0K
Debt$450.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 26.2% shares (2026Q1 vs prior)
68 institutional holders · 44.25M shares
#1 MMCAP International Inc. SPC 2.70M shares
#2 Magnetar Financial LLC 2.70M shares
#3 Karpus Management, Inc. 2.60M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest135.3K
Days to Cover1.4
% of Float0.3%
FINRA data as of Jul 31, 2026

Recent SEC Activity

8-K 8K EVENT 2026-04-28
8-K 8K EVENT 2026-04-03
8-K 8K EVENT 2026-03-17
Full SEC filing analysis available with free account

Recent News

No recent news

Factual DMII Dilution Snapshot

Drugs Made In America Acquisition II Corp. (DMII) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track DMII Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMII — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DMII
DMII FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.